Perrigo PRGO
Revenue per employee
8,100 employees as of 2025/FY (-3.3% YoY). Revenue per employee is total revenue divided by headcount — a rough productivity gauge, not a per-worker pay figure.
Management team
Background
Eduardo Bezerra joined Perrigo in May 2022 as Executive Vice President and Chief Financial Officer. Mr. Bezerra previously served as Senior Vice President and Chief Financial Officer for Del Monte Fresh Produce, Inc., from 2019 to 2022. Before that, Mr. Bezerra held a number of positions of increasing responsibility at Monsanto Company from 1998 to 2018.
Background
Roberto Khoury was named Executive Vice President and Chief Commercial Officer in July 2025 after serving as Executive Vice President and President, Consumer Self Care International. He joined Perrigo in May 2024 after more than six years with Kenvue (formerly a part of Johnson & Johnson), where he was Senior Vice President and General Manager of their skin care portfolio, including brand leadership responsibilities. Prior to that role he led Kenvue's consumer brands in Europe. Before his time at Kenvue, Mr. Khoury spent 13 years at L'Oreal, where he held several leadership roles in the consumer space that included stints in growing pan-European line extensions of leading brands.
Background
Orlando D. Ashford, Chairman of the Board. Experience February 2025 - Present: Interim CEO, National Black MBA Association October 2025 - Present: Operating Advisor, 65 Equity Partners, a global, entrepreneur-led, investment firm 2022 - January 2025: Chief People Officer, Fanatics Holdings Inc, a global sporting company 2021 - 2022: Executive Chairman, Azamara Cruise Lines, a worldwide cruise line company 2014 - 2020: President, Holland America Line, a worldwide cruise line company 2020 - 2021: Strategic Advisor, Sycamore Partners, a private equity firm. Other Public Company Directorships 2020 - Present: Array Technologies Inc. (NASDAQ: ARRY) 2011 - 2022: ITT, Inc. (NYSE: ITT).
Background
Donal O'Connor, Independent Director. Experience 2011 - Present: Chairman, Huttonread 2010 - Jan. 2026: Chairman, Galco Steel Ltd, Ireland's leading steel galvanizing company 1983 - 2007: Partner, Partner in Charge, Leader, Senior Partner, PwC Ireland, Ireland's largest assurance, advisory and tax services network of firms. Other Public Company Directorships 2015 - Present: Theravance Biopharma Inc (NASDAQ: TBPH) 2017 - 2018: Malin Corporation plc (ISE: MLC) 2008 - 2013: Elan Corporation plc (prior to Perrigo's acquisition of Elan).
Background
Bradley A. Alford, Independent Director. Experience: 2016 - 2021 Operating Partner, Advent International Corporation, a global private equity firm.; 2014 - 2016 Industry Advisor, Advent International Corporation.; 2006 - 2013 Chairman / CEO, Nestle USA, a multinational food and beverage company. Other Public Company Directorships: July 2025 - Present: Lamb Weston Holdings Inc. (NYSE: LW) Lead Independent Director (previously Chairman from July 2025 to February 2026); 2010 - Present Avery Dennison Corporation (NYSE: AVY), Compensation Committee and Nominating and Governance Committee; 2015 - 2018 Conagra Brands, Inc. (NYSE: NCAG); 2006 - 2013 Nestle USA (OTCMKTS: NSRGY).
Background
Geoffrey M. Parker, Independent Director. Experience 2023 - Present: Executive Vice President & Chief Financial Officer, Allogene Therapeutics, Inc, a biotechnology company 2017 - 2023: Chief Operating Officer & Chief Financial Officer, Tricida, Inc, a biotechnology company 2010 - 2015: Chief Financial Officer, Anacor Pharmaceuticals, Inc., a biotechnology company 1997 - 2009: Managing Director and Partner, Healthcare Investment Banking, Goldman Sachs, a multinational investment bank and financial service company. Other Public Company Directorships 2021 - March 2024: Better Therapeutics (NASDAQ: BTTX) 2009 - 2022: ChemoCentryx (NASDAQ: CCXI) 2016 - 2019: Genomic Health (NASDAQ: GHDX) 2016 - 2017: Sunesis Pharmaceuticals (NASDAQ: SNSS).
Background
On June 7, 2026, the Board appointed Albert A. Manzone, Director and member of the Audit Committee of the Board, as the Company's Interim President and Chief Executive Officer. Albert A. Manzone is a global executive with more than 30 years of leadership experience across consumer goods, consumer health, luxury and hospitality. He has led businesses at global scale, with a track record of transforming companies at inflection points and creating value. He has served as a member of the Perrigo Board of Directors since 2022. Most recently, he was Deputy Chief Executive Officer of Monte-Carlo Societe des Bains de Mer, a premier luxury hospitality group, where he drove operational performance and strengthened the leadership team across three consecutive record years. Previously, he served as Chief Executive Officer of Whole Earth Brands, a global food company. Earlier in his career, he was President Europe at Oettinger Davidoff AG and held senior leadership roles at Novartis Consumer Health, W.M. Wrigley Jr. Company, PepsiCo, and McKinsey & Company. He currently serves as a director at Syntec Optics Holdings (NASDAQ: OPTX). He holds an MBA from the Kellogg School of Management at Northwestern University and a postgraduate degree in international business from Sorbonne University.
Background
Ms. Julia M. Brown, Independent Director. Experience 2020 - 2021: Chief Procurement & Sustainability Officer, Mars Wrigley, a world leading manufacturer of chocolate and confectionery 2015 - 2020: Chief Procurement Officer, Carnival Corporation & plc, the world's largest global cruising company with nine major brands. Other Public Company Directorships 2023 - Present: Ocado plc (LSE: OCDO) 2021 - May 2025: Molson Coors Beverage Company (NYSE: TAP) 2021 - January 2025: Solo Brands Inc. (NYSE: DTC) 2022 - 2023: Honest Company Inc. (NASDAQ: HNST).
Background
On June 30, 2026, the Board of Directors of Perrigo Company plc appointed Omer Gajial to serve as member of the Board effective as of June 30, 2026. Mr. Gajial, is a seasoned executive with extensive experience in retail, e-commerce and consumer health. He currently serves as Chief Executive Officer of GoTo Foods, a franchisor and operator of more than 7,000 restaurant and retail locations globally across multiple brands. Prior to this role, Mr. Gajial served as Executive Vice President and Chief Merchandising & Digital Officer at Albertsons Companies.
Background
On June 30, 2026, the Board of Directors of Perrigo Company plc appointed Salman Amin to serve as member of the Board effective as of June 30, 2026. Mr. Amin, age 66, is an experienced executive with more than 30 years in the global consumer products industry. He most recently served as Chief Executive Officer of pladis Global, where he led a multi-year transformation that delivered sustained revenue growth and improved profitability. Previously, Mr. Amin served as Chief Operating Officer of the Global Commercial Division at SC Johnson and held senior leadership roles at PepsiCo and Procter & Gamble.
Background
Mr. Kevin Egan, Independent Director. Experience 1998 - 2024: Partner, Audit and Assurance, PwC Ireland, a multinational provider of audit, assurance, advisory and tax services worldwide 2007 - 2015: Head of Audit and Assurance, PwC Ireland 2021 - Present: Member of the Audit Committee of the National University of Ireland.
Background
Mr. Jonas Samuelson, Experience 2016 - January 2025: President & CEO, AB Electrolux (XSTO: ELUX A), one of the world's largest home appliance manufacturers 2011 - 2016: CEO, Major Appliances, Electrolux Europe, Middle East and Africa 2008 - 2011: CFO, Electrolux Group 2005 - 2008: CFO and EVP, Munters AB, a temperature, humidity and air quality technologies and systems provider. Other Public Company Directorships March 2026 - Present: Ansell Ltd. (ASX: ANN) August 2020 - Present: AB Volvo (NASDAQ Stockholm: VOLV) 2016 - January 2025: AB, Electrolux (XSTO: ELUX A).
Background
Dr. Ball was named Executive Vice President and Chief Brand and Digital Officer in August 2024. Prior to joining Perrigo, Dr. Ball was most recently at Bayer Consumer Healthcare and Care/of (prior to its acquisition by Bayer in 2020) from 2019 to 2024, where he held various positions including General Manager and Vice President of Marketing for the Digestive Health business in North America. Prior to this, Dr. Ball spent more than eight years at Procter and Gamble in leadership positions across multiple business units and functions.
Background
Abbie Lennox was named Executive Vice President and Chief Science Officer in January 2025. Ms. Lennox joined Perrigo from Bayer where she served as Executive Committee Member and Chief Trust and Science Officer from 2019 to 2024, responsible for leading the regulatory, medical affairs, safety and quality teams. Prior to her time at Bayer, she served in regulatory affairs leadership roles with Reckitt Benckiser, where she advanced the company's regulatory approach to pipeline delivery across multiple health and wellness brands.
Background
Mr. Willis was named Executive Vice President and Chief Human Resources Officer in March 2019 after serving as Vice President of Human Resources Global Businesses for nearly six years. Prior to joining Perrigo, Mr. Willis gained more than 20 years of experience in Human Resources leadership through roles with Fawaz Alhokair Group, GE Capital, DoubleClick, and Norkom Technologies.
Background
Charles Atkinson was named Executive Vice President, General Counsel & Secretary, in October 2024. Mr. Atkinson joined Perrigo from Haleon plc and its predecessor, GSK plc, most recently serving as Interim General Counsel. During his 20-plus year combined tenure at Haleon/GSK, Mr. Atkinson successfully advised across numerous transactions and integrations, including the creation of Haleon and subsequent separation from its parent shareholders GSK and Pfizer. He has also served as global head of corporate legal and was lead counsel for various parts of the self-care business, including supply chain, R&D and innovation, business development, and intellectual property.
Background
Matt Winterman was named Executive Vice President, Product Supply, Operations Strategy and Transformation Officer, in June 2025. Mr. Winterman has more than 20 years of global supply chain and strategy leadership. Prior to joining Perrigo, Mr. Winterman served as Senior Vice President of Global Supply Chain and Strategy at AstraZeneca from 2023 to 2025. In this capacity, he was instrumental in driving transformation and strategic investment in the manufacturing network. He also served as Global Head of end-to-end Supply Chain at Roche Holding AG from 2018 to 2023, and prior to that in roles of increasing responsibility for technical operations strategy and supply chain performance at GSK plc.
From SEC filings, via Futu. Compensation is total reported pay for the most recent fiscal year on file, not base salary alone.
No comments yet — be the first to weigh in on PRGO.
Sign in to join the discussion.